Surfactant therapy for hyaline membrane disease: The Chandigarh experience

Indian Pediatrics

Volumn 38, Issue 6, 2001, Pages 640-646

  Narang, Anil ^a,b   Kumar, Praveen ^a   Dutta, Sourabh ^a   Kumar, Rajesh ^a  

^a Department of Pediatrics   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; INDOMETACIN; LUNG SURFACTANT EXTRACT; SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CHILD HOSPITALIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HIGH RISK PATIENT; HUMAN; HYALINE MEMBRANE DISEASE; INCINERATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN MORTALITY; NEWBORN SEPSIS; PATENT DUCTUS ARTERIOSUS; PREMATURITY; PROPHYLAXIS; RESPIRATORY DISTRESS; SEPTICEMIA; SURVIVAL RATE;

BIOLOGICAL PRODUCTS; DRUG COMBINATIONS; FATTY ALCOHOLS; FEMALE; HUMANS; HYALINE MEMBRANE DISEASE; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PHOSPHORYLCHOLINE; POLYETHYLENE GLYCOLS; PULMONARY SURFACTANTS;

EID: 0034955975     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Nagesh K, Bhat V, Kunikullya S, Rajesh N. Surfactant therapy in neonatal respiratory distress syndrome. Indian Pediatr 1994; 31: 971-977.
2. Sanghvi KP, Merchant RH. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome. Indian Pediatr 1998; 35: 533-536.
3. Neonatal morbidity and mortality: Report of the National Neonatal Perinatal Database. Indian Pediatr 1997; 34: 1089-1092.
4. Kumar P, Kumar R, Narang A. Spectrum of neonatal respiratory distress at PGI. Bull NNF 1999; 13(4): 8-12.
5. Singh M, Deorari K, Aggarwal R, Paul VK. Assisted ventilation for hyaline membrane disease. Indian Pediatr 1995; 32: 1267-1274.
6. Bhakoo ON, Narang A, Ghosh K. Assisted ventilation in neonates: An experience with 120 cases. Paper presented at IX Annual Conference, National Neonatology Forum, Manipal, February 17-20, 1990.
7. Bhakoo ON. Assisted ventilation in neonates: The Indian perspective. Indian Pediatr 1995; 32: 1261-1264.
8. Maiya PP, Viswanath D, Hegde S, Srinivas TP, Shivaprasad, Shantaia CC, et al. Mechanical ventilation of newborns: Experience from a level II NICU. Indian Pediatr 1995; 32: 1275-1280.
9. Narang A. Tiny neonates; Management and follow-up. Indian Pediatr 1993; 30: 1393-1395.
10. Soll RF, McQueen MC. Respiratory distress syndrome. In: Effective Care of the Newborn. Eds. Sinclair JC, Bracken MB. Oxford; Oxford University Press, 1992; pp 325-352.
11. Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ. Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500-1500g. N Engl J Med 1994; 330: 1476-1480.
12. Hammerman G. Patent ductus arteriosus: Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology treatment. Clin Perinatol 1995; 22: 457-479.
13. Saez-Liorens X, McCracken GH Jr. Sepsis syndrome and septic shock in pediatrics: Current concept in terminology, pathophysiology, and management. J Pediatr 1993; 123: 497-508.
14. Tubman TRJ, Halliday HL, Normand C. Cost of Surfactant replacement treatment for severe neonatal respiratory distress syndrome: A randomized controlled trial. Brit Med J 1990; 301: 842-845.
15. Al-Umran K, yaseen K. Cost-effectiveness of surfactant replacement therapy in a developing country. J Trop Pediatr 1997; 43: 167-169.
16. Sidner SR, Ikegami M, Yamada T, Rider ED, Castror, Jobe AH. Decreased surfactant dose response after delayed administration to preterm rabbits. Am J Respir Crit Care Med 1995; 152: 113-120.
17. Morley CJ. Systematic review of prophylactic vs rescue surfactant. Arch Dis Child 1997; 77: F70-F77.
18. Verder H, Robertson B, Grisen G, Ebbesen F, Albertson P, Windstron K, et al. Surfactant therapy and nasal CPAP for newborn with RDS. N Engl J Med 1994; 331: 1051-1055.